StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Price Performance
Shares of BTX opened at $0.84 on Thursday. Brooklyn ImmunoTherapeutics has a 12 month low of $0.17 and a 12 month high of $10.10. The stock has a fifty day moving average price of $1.17 and a 200 day moving average price of $1.62. The company has a market cap of $49.12 million, a P/E ratio of -0.37 and a beta of 4.61.
About Brooklyn ImmunoTherapeutics
See Also
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What is the FTSE 100 index?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- The 3 Best Blue-Chip Stocks to Buy Now
- Time to Load Up on Home Builders?
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
